Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
07 07 2022
Historique:
received: 05 04 2022
accepted: 22 05 2022
entrez: 7 7 2022
pubmed: 8 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

Frontotemporal dementia is characterized by progressive atrophy of frontal and/or temporal cortices at an early age of onset. The disorder shows considerable clinical, pathological, and genetic heterogeneity. Here we investigated the proteomic signatures of frontal and temporal cortex from brains with frontotemporal dementia due to GRN and MAPT mutations to identify the key cell types and molecular pathways in their pathophysiology. We compared patients with mutations in the GRN gene (n = 9) or with mutations in the MAPT gene (n = 13) with non-demented controls (n = 11). Using quantitative proteomic analysis on laser-dissected tissues we identified brain region-specific protein signatures for both genetic subtypes. Using published single cell RNA expression data resources we deduced the involvement of major brain cell types in driving these different protein signatures. Subsequent gene ontology analysis identified distinct genetic subtype- and cell type-specific biological processes. For the GRN subtype, we observed a distinct role for immune processes related to endothelial cells and for mitochondrial dysregulation in neurons. For the MAPT subtype, we observed distinct involvement of dysregulated RNA processing, oligodendrocyte dysfunction, and axonal impairments. Comparison with an in-house protein signature of Alzheimer's disease brains indicated that the observed alterations in RNA processing and oligodendrocyte function are distinct for the frontotemporal dementia MAPT subtype. Taken together, our results indicate the involvement of different brain cell types and biological mechanisms in genetic subtypes of frontotemporal dementia. Furthermore, we demonstrate that comparison of proteomic profiles of different disease entities can separate general neurodegenerative processes from disease-specific pathways, which may aid the development of disease subtype-specific treatment strategies.

Identifiants

pubmed: 35799292
doi: 10.1186/s40478-022-01387-8
pii: 10.1186/s40478-022-01387-8
pmc: PMC9261008
doi:

Substances chimiques

GRN protein, human 0
Intercellular Signaling Peptides and Proteins 0
MAPT protein, human 0
Progranulins 0
tau Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Informations de copyright

© 2022. The Author(s).

Références

Nature. 2015 Sep 3;525(7567):129-33
pubmed: 26308899
J Exp Neurosci. 2016 Feb 10;9(Suppl 2):43-50
pubmed: 26884683
J Proteome Res. 2009 Nov;8(11):5069-79
pubmed: 19746990
Mol Biosyst. 2009 Dec;5(12):1512-26
pubmed: 20023718
CNS Drugs. 2009 Nov;23(11):915-26
pubmed: 19845413
Neurochem Int. 2017 Oct;109:202-209
pubmed: 28235551
Cell Syst. 2017 Apr 26;4(4):404-415.e5
pubmed: 28330615
EMBO J. 2017 Oct 16;36(20):2931-2950
pubmed: 28916614
Nature. 2019 Sep;573(7772):61-68
pubmed: 31435019
Sci Rep. 2018 Jun 11;8(1):8868
pubmed: 29892006
Neuropathol Appl Neurobiol. 2019 Feb;45(1):19-40
pubmed: 30357887
Int J Mol Sci. 2018 Dec 20;20(1):
pubmed: 30577465
Lancet Neurol. 2014 Jul;13(7):686-99
pubmed: 24943344
Transl Psychiatry. 2018 Apr 11;8(1):73
pubmed: 29636460
Mol Neurobiol. 2020 Jul;57(7):2959-2980
pubmed: 32445085
Curr Opin Hematol. 2015 Jan;22(1):53-9
pubmed: 25427141
BMC Genomics. 2017 Apr 18;18(1):305
pubmed: 28420336
Eur J Immunol. 2015 Apr;45(4):1043-58
pubmed: 25545837
J Neurol. 2019 Aug;266(8):2075-2086
pubmed: 31119452
Biochim Biophys Acta. 2015 Jul;1854(7):827-33
pubmed: 25707359
Neuron. 2013 Aug 7;79(3):416-38
pubmed: 23931993
Nucleic Acids Res. 2021 Jan 8;49(D1):D1541-D1547
pubmed: 33174596
Neurobiol Aging. 2015 Oct;36(10):2904.e13-26
pubmed: 26154020
Neuron. 2019 Jul 17;103(2):217-234.e4
pubmed: 31171447
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
PLoS Med. 2018 Jan 9;15(1):e1002487
pubmed: 29315334
Neurobiol Aging. 2018 Feb;62:191-196
pubmed: 29172163
Front Neurol. 2011 Apr 25;2:24
pubmed: 21577247
Brain. 2011 Sep;134(Pt 9):2565-81
pubmed: 21908872
Mol Cell Proteomics. 2015 May;14(5):1400-10
pubmed: 25724911
Lancet. 2015 Oct 24;386(10004):1672-82
pubmed: 26595641
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
J Proteome Res. 2012 Apr 6;11(4):2533-43
pubmed: 22360420
J Neurosci. 2013 Dec 11;33(50):19579-89
pubmed: 24336722
Int J Mol Sci. 2021 Sep 24;22(19):
pubmed: 34638637
Neurobiol Aging. 2017 Mar;51:104-112
pubmed: 28061383
Sci Rep. 2015 Jun 08;5:10775
pubmed: 26053859
Neurobiol Dis. 2020 Aug;142:104957
pubmed: 32512150
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):126-138
pubmed: 28088537
Trends Genet. 2018 Jun;34(6):404-423
pubmed: 29605155
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Mol Syst Biol. 2016 Oct 20;12(10):883
pubmed: 27951527
Genome Biol. 2003;4(9):117
pubmed: 12952525
Nat Biotechnol. 2018 Jan;36(1):70-80
pubmed: 29227469
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Nat Commun. 2020 Jul 3;11(1):3354
pubmed: 32620797
Nat Methods. 2019 Sep;16(9):809-812
pubmed: 31406385
Neurology. 2008 Oct 14;71(16):1220-6
pubmed: 18703462
Sci Rep. 2017 Aug 21;7(1):8899
pubmed: 28827549
Ann Neurol. 2012 Dec;72(6):837-49
pubmed: 23280835
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7285-90
pubmed: 26060301
Int J Mol Sci. 2020 Mar 17;21(6):
pubmed: 32192109
Sci Rep. 2016 May 04;6:24799
pubmed: 27142790
Cell Rep. 2019 Jan 15;26(3):582-593.e5
pubmed: 30650353
J Alzheimers Dis. 2019;68(3):1287-1307
pubmed: 30909235
J Proteomics. 2019 Jun 15;201:37-47
pubmed: 30999060
Neurology. 2009 Nov 3;73(18):1451-6
pubmed: 19884572
J Proteome Res. 2019 Apr 5;18(4):1787-1795
pubmed: 30768908
EMBO Mol Med. 2018 Jan;10(1):48-62
pubmed: 29191947
J Neurosci. 2005 Oct 12;25(41):9434-43
pubmed: 16221853
Nucleic Acids Res. 2016 Jul 8;44(W1):W83-9
pubmed: 27098042
Neurology. 2001 Jun;56(11 Suppl 4):S35-40
pubmed: 11402149
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Bioinformatics. 2018 Jun 1;34(11):1969-1979
pubmed: 29351586
Sci Adv. 2020 Jul 22;6(30):eaba2619
pubmed: 32832661
Nat Rev Neurol. 2019 Sep;15(9):540-555
pubmed: 31324897
Proteomes. 2018 Dec 09;6(4):
pubmed: 30544872
J Neurochem. 2016 Aug;138 Suppl 1:54-70
pubmed: 27306735
Clin Pract Epidemiol Ment Health. 2013 Jun 14;9:88-95
pubmed: 23878613
Front Neurosci. 2016 Jan 27;10:16
pubmed: 26858593
Nat Neurosci. 2018 Feb;21(2):228-239
pubmed: 29311743
J Mol Neurosci. 2011 Nov;45(3):384-9
pubmed: 21720721
J Neuroinflammation. 2020 Aug 10;17(1):234
pubmed: 32778130

Auteurs

Suzanne S M Miedema (SSM)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands. s.s.m.miedema@vu.nl.

Merel O Mol (MO)

Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.

Frank T W Koopmans (FTW)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

David C Hondius (DC)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

Pim van Nierop (P)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

Kevin Menden (K)

German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.

Christina F de Veij Mestdagh (CF)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.
Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, the Netherlands.
Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.

Jeroen van Rooij (J)

Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Andrea B Ganz (AB)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.
Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.

Iryna Paliukhovich (I)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

Shamiram Melhem (S)

Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.

Ka Wan Li (KW)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

Henne Holstege (H)

Alzheimer Center, Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
Department of Clinical Genetics, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.

Patrizia Rizzu (P)

German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.

Ronald E van Kesteren (RE)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

John C van Swieten (JC)

Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.

Peter Heutink (P)

German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Tübingen, Germany.

August B Smit (AB)

Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, W&N Building, C314. De Boelelaan 1105, 1081 HV, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH